I 115th CONGRESS 1st Session H. R. 4117 IN THE HOUSE OF REPRESENTATIVES October 25, 2017 Mr. Doggett (for himself, Mr. Cummings , Ms. DeLauro , Ms. Schakowsky , Mr. Pocan , Ms. Judy Chu of California , Mr. Cicilline , Mr. Cohen , Mr. Conyers , Mr. Ellison , Mr. Grijalva , Ms. Kaptur , Mr. Khanna , Mr. Langevin , Mr. Nadler , Mrs. Napolitano , Mr. O'Rourke , Ms. Pingree , Ms. Castor of Florida , Mr. Raskin , and Ms. Velázquez ) introduced the following bill; which was referred to the Committee on Ways and Means , and in addition to the Committees on the Judiciary , and Energy and Commerce , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes.